- Home
- CAAS vs VRCA Comparison
CAAS vs VRCA Comparison
Compare CAAS & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CAAS | VRCA |
|---|---|---|
| Founded | N/A | 2013 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 130.6M | 112.4M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | CAAS | VRCA |
|---|---|---|
| Price | $4.40 | $5.51 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $17.00 |
| AVG Volume (30 Days) | 18.6K | ★ 149.0K |
| Earning Date | 03-27-2026 | 03-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 5.68 | N/A |
| EPS | ★ 1.11 | N/A |
| Revenue | ★ $725,260,000.00 | $30,829,000.00 |
| Revenue This Year | N/A | $372.93 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $4.03 | ★ N/A |
| Revenue Growth | 16.72 | ★ 234.73 |
| 52 Week Low | $3.50 | $3.28 |
| 52 Week High | $5.37 | $9.82 |
Technical Indicators
Market Signals| Indicator | CAAS | VRCA |
|---|---|---|
| Relative Strength Index (RSI) | 46.82 | 29.38 |
| Support Level | $4.33 | $5.41 |
| Resistance Level | $4.70 | $5.97 |
| Average True Range (ATR) | 0.14 | 0.45 |
| MACD | -0.01 | -0.18 |
| Stochastic Oscillator | 31.58 | 4.53 |
Price Performance
Historical ComparisonAbout CAAS China Automotive Systems Inc.
China Automotive Systems Inc is a holding company. The firm through its subsidiary is a supplier of power steering systems and components to China's automotive industry. Its product offering encompasses a full range of auto parts incorporated into steering systems for both passenger automobiles and commercial vehicles. The company offers four separate series, models of power steering including rack and pinion power steering, integral power steering, electronic power steering and manual steering, steering columns, steering oil pumps, and steering hoses. Geographically, it derives a majority of its revenue from China.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.